UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000037086 |
|---|---|
| Receipt number | R000042257 |
| Scientific Title | Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers |
| Date of disclosure of the study information | 2019/06/17 |
| Last modified on | 2019/06/17 12:42:18 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Acronym
Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Scientific Title
Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Scientific Title:Acronym
Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Region
| Japan |
Condition
Condition
hereditary breast and ovarian cancer
Classification by specialty
| Breast surgery | Obstetrics and Gynecology |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
To evaluate the safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Perioperative complications related to risk reducing salpingo-oophorectomy
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
risk reducing salpingo-oophorectomy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 35 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
1. BRCA1/2 mutant carriers
2. Women who give informed consent about risk reducing salpingo-oophorectomy
Key exclusion criteria
1. Women who desire having babies
2. Women with ovarian or tubal cancer
3. Physician decision
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Satoru |
| Middle name | |
| Last name | Kyo |
Organization
Shimane University Faculty of Medicine
Division name
Department of Obstetrics and Gynecology
Zip code
693-8501
Address
89-1 Enya-cho Izumo-shi, Shimane, Japan
TEL
+81-853-20-2268
satoruky@med.shimane-u.ac.jp
Public contact
Name of contact person
| 1st name | Kentaro |
| Middle name | |
| Last name | Nakayama |
Organization
Shimane University Faculty of Medicine
Division name
Department of Obstetrics and Gynecology
Zip code
693-8501
Address
89-1 Enya-cho Izumo-shi, Shimane, Japan
TEL
+81-853-20-2268
Homepage URL
kn88@med.shimane-u.ac.jp
Sponsor or person
Institute
Shimane University Faculty of Medicine
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Bio Ethical Committee in Shimane University Hospital
Address
89-1 Enya-cho Izumo-shi, Shimane, Japan
Tel
+81-853-20-2259
kenkyu@med.shimane-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 06 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2017 | Year | 04 | Month | 26 | Day |
Date of IRB
| 2017 | Year | 05 | Month | 01 | Day |
Anticipated trial start date
| 2017 | Year | 05 | Month | 01 | Day |
Last follow-up date
| 2027 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2019 | Year | 06 | Month | 17 | Day |
Last modified on
| 2019 | Year | 06 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042257
